Gene enrichment analyses indicated that LZTS3 expression levels correlate with immune checkpoint inhibition, emphasizing the therapeutic potential of LZTS3 for colorectal adenocarcinoma (COAD). This evidence concerns the gene LZTS3 and colorectal adenocarcinoma.